Global Continuous Glucose Monitoring Systems Market Set to Skyrocket to US$ 103.5 Billion by 2033, Driven by Technological Advancements and Increasing Diabetes Prevalence | FMI

According to a new report, the global continuous glucose monitoring systems market, valued at US$ 11.1 billion in 2023, is projected to experience a meteoric rise, reaching an estimated US$ 103.5 billion by 2033. This represents a robust compound annual growth rate (CAGR) of 25.1% during the forecast period.

The surging market growth is primarily fueled by the rising prevalence of diabetes globally and the enhanced capability of Continuous glucose monitoring systems to provide real-time, accurate monitoring of blood glucose levels around the clock. Unlike traditional fingerstick glucose tests, Continuous glucose monitoring systems offer comprehensive and immediate glucose level insights, which are crucial for effective diabetes management.

Get Access to Sample Now:

Healthcare providers and patients are increasingly turning to Continuous glucose monitoring systems due to their rapid response times and advanced sensor technology. These features are essential for timely adjustments in treatment plans and for reducing potential complications associated with diabetes.

Moreover, technological advancements are continuously being made in the development of Continuous glucose monitoring systems to enhance their reliability, accuracy, and user-friendliness. These improvements are making Continuous glucose monitoring systems devices more appealing to a broader demographic, including aging populations and those newly diagnosed with diabetes.

“Continuous glucose monitoring systems are revolutionizing diabetes management by providing patients with seamless, automatic adjustments to their blood sugar levels,” said FMI. “This not only improves patient outcomes by minimizing the risk of diabetes-related complications but also integrates smoothly with insulin pumps, making daily diabetes management more effective and less intrusive.”

The expansion of the Continuous glucose monitoring systems market is also being supported by favorable reimbursement policies, which are making these advanced systems more accessible to a wider range of patients. Additionally, the integration of artificial intelligence and the adoption of telemedicine solutions are propelling the market forward, offering new avenues for growth and innovation.

As diabetes continues to be a major health issue worldwide, the demand for reliable and easy-to-use continuous glucose monitoring systems is expected to surge, thereby significantly driving market expansion over the next decade.

Key Takeaways: Continuous Glucose Monitoring Systems Market

  • The continuous glucose monitoring systems market is expected to experience significant growth US$ 11.1 billion in 2023, with estimates ranging from a CAGR of 25.1%. This translates to a market size exceeding US$ 103.5 billion by 2033.
  • The primary driver of this growth is the rising prevalence of diabetes worldwide, along with increasing awareness about the benefits of Continuous glucose monitoring systems for managing the condition.
  • The Asia Pacific region is anticipated to witness the fastest growth in the Continuous glucose monitoring systems market, likely due to factors like a growing diabetic population and developing healthcare infrastructure.
  • Other significant factors propelling the market forward include:
    • Growing geriatric population, a demographic more susceptible to diabetes.
    • Increasing demand for better diabetes diagnostics and management tools.
    • The need to address unmet healthcare needs, particularly in developing regions.

These trends indicate a promising future for the Continuous glucose monitoring systems market, with continuous advancements likely to further improve accessibility and efficacy for diabetes management.

Methodology Details Just a Click Away:

Key Players in the Continuous Glucose Monitoring Systems Market:

  • Herbalife Nutrition
  • GNC Holdings
  • NOW Health
  • Nutramax Laboratories
  • Nature’s Bounty
  • Banyan Botanicals
  • Source Naturals
  • Nutramarks Inc
  • Nature’s Way Products
  • Abbott
  • Natural Immunogenics
  • Solaray Inc.
  • Sambucol USA
  • Quantum Health, Inc.
  • Vitabiotics Ltd.
  • Rainbow Light
  • AdvoCare
  • Pure Encapsulations, LLC.
  • Country Life, LLC
  • Natural Health Concept

Key Segments in the Continuous Glucose Monitoring Systems Market:

By Components:

  • Transmitters and Monitors
  • Sensors
  • Insulin Pump

By End-use Sector:

  • Home Care Diagnostics
  • Hospitals
  • ICU/Critical Care

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Direct Purchase of this Report:

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

Matched content

Editor’s pick

Express Press Release Distribution